Cargando…
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
The TWEAK/Fn14 pathway is now well-known for its involvement in the modulation of inflammation in various human autoimmune/chronic inflammatory diseases (AICID) including lupus, rheumatoid arthritis, and multiple sclerosis. A panel of data is now available concerning TWEAK expression in tissues or b...
Autores principales: | Bertin, Daniel, Stephan, Delphine, Khrestchatisky, Michel, Desplat-Jégo, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873518/ https://www.ncbi.nlm.nih.gov/pubmed/24409182 http://dx.doi.org/10.3389/fimmu.2013.00489 |
Ejemplares similares
-
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier
por: Stephan, Delphine, et al.
Publicado: (2013) -
High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
por: Maarouf, Adil, et al.
Publicado: (2019) -
TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy
por: Guis, Sandrine, et al.
Publicado: (2016) -
Targeting TNF and Its Family Members in Autoimmune/Inflammatory Disease
por: Desplat-Jégo, Sophie, et al.
Publicado: (2014) -
TWEAK and TNFα, Both TNF Ligand Family Members and Multiple Sclerosis-Related Cytokines, Induce Distinct Gene Response in Human Brain Microvascular Endothelial Cells
por: Stephan, Delphine, et al.
Publicado: (2022)